Abetimus

Abetimus Uses, Dosage, Side Effects, Food Interaction and all others data.

Abetimus was developed by La Jolla Pharmaceuticals as an immunosuppressant but was never marketed in American or Europe despite application for marketing authorization in the mid-2000s.

Trade Name Abetimus
Generic Abetimus
Abetimus Other Names Abetimus
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Abetimus
Abetimus

Uses

Investigated for use/treatment in kidney disease and systemic lupus erythematosus.

Innovators Monograph

You find simplified version here Abetimus

*** Taking medicines without doctor's advice can cause long-term problems.
Share